Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta M Alonso

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Vaccines|February 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center SeriesInés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2024
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceDong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Journal of the National Cancer Institute|November 3, 2005
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significanceMarta M Alonso, Juan Fueyo, Jerry W Shay, et al.
Glia|November 10, 2022
Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's diseaseLeyre Basurco, Miguel Angel Abellanas, Leyre Ayerra, et al.
Oncotarget|December 1, 2016
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patientsNoemí García-Romero, Josefa Carrión-Navarro, Susana Esteban-Rubio, et al.
Molecular Therapy Oncolytics|August 11, 2022
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcomaGuillermo Herrador-Cañete, Marta Zalacain, Sara Labiano, et al.
Plos One|November 10, 2011
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasMarta M Alonso, Ricardo Diez-Valle, Lorea Manterola, et al.
Neuro-Oncology Advances|July 10, 2020
RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastasesMontserrat Puigdelloses, Marisol González-Huárriz, Marc García-Moure, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Molecular Therapy. Oncology|May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profilesKonstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Vaccines|February 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center SeriesInés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2024
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceDong Ho Shin, Hong Jiang, Andrew G Gillard, et al.
Journal of the National Cancer Institute|November 3, 2005
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significanceMarta M Alonso, Juan Fueyo, Jerry W Shay, et al.
Glia|November 10, 2022
Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's diseaseLeyre Basurco, Miguel Angel Abellanas, Leyre Ayerra, et al.
Oncotarget|December 1, 2016
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patientsNoemí García-Romero, Josefa Carrión-Navarro, Susana Esteban-Rubio, et al.
Molecular Therapy Oncolytics|August 11, 2022
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcomaGuillermo Herrador-Cañete, Marta Zalacain, Sara Labiano, et al.
Plos One|November 10, 2011
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasMarta M Alonso, Ricardo Diez-Valle, Lorea Manterola, et al.
Neuro-Oncology Advances|July 10, 2020
RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastasesMontserrat Puigdelloses, Marisol González-Huárriz, Marc García-Moure, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Molecular Therapy. Oncology|May 2, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profilesKonstantinos Vazaios, Εftychia Stavrakaki, Lisette B Vogelezang, et al.
Pageof 11